L’utilisation des médicaments chez les personnes atteintes de trouble neurocognitif majeur
Wed, 29 Jan 2025 12:04:32 -0500
Italiano
Wed, 29 Jan 2025 12:04:32 -0500
Wed, 29 Jan 2025 10:01:16 -0500
Collegeville, Pennsylvania, Provepharm Inc. is voluntarily recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk Package) at the hospital/institutional level. This recall was initiated based on a customer complaint from a pha
Thu, 23 Jan 2025 10:53:56 -0500
Thu, 23 Jan 2025 10:11:55 -0500
Thu, 23 Jan 2025 09:35:46 -0500
Wed, 22 Jan 2025 17:41:44 -0500
Wed, 22 Jan 2025 16:42:29 -0500
Wed, 22 Jan 2025 16:03:40 -0500
Le bulévirtide devrait être indiqué dans le traitement de l’infection au virus de l’hépatite D chez l’adulte atteint de maladie hépatique compensée.
The FDA is warning about the risk of a rare but serious allergic reaction with the medicine glatiramer acetate (Copaxone, Glatopa), which is used to treat patients with multiple sclerosis (MS). This serious allergic reaction, called anaphylaxis, can occur at any time while on treatment, after the fi
80.211.154.110